CoChat

Exercise Capacity and Mortality among Men Referred for Exercise Testing

Open access

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Exercise capacity is known to be an important prognostic factor in patients with cardiovascular disease, but it is uncertain whether it predicts mortality equally well among healthy persons. There is also uncertainty regarding the predictive power of exercise capacity relative to other clinical and exercise-test variables. METHODS: We studied a total of 6213 consecutive men referred for treadmill exercise testing for clinical reasons during a mean (+/-SD) of 6.2+/-3.7 years of follow-up. Subjects were classified into two groups: 3679 had an abnormal exercise-test result or a history of cardiovascular disease, or both, and 2534 had a normal exercise-test result and no history of cardiovascular disease. Overall mortality was the end point. RESULTS: There were a total of 1256 deaths during the follow-up period, resulting in an average annual mortality of 2.6 percent. Men who died were older than those who survived and had a lower maximal heart rate, lower maximal systolic and diastolic blood pressure, and lower exercise capacity. After adjustment for age, the peak exercise capacity measured in metabolic equivalents (MET) was the strongest predictor of the risk of death among both normal subjects and those with cardiovascular disease. Absolute peak exercise capacity was a stronger predictor of the risk of death than the percentage of the age-predicted value achieved, and there was no interaction between the use or nonuse of beta-blockade and the predictive power of exercise capacity. Each 1-MET increase in exercise capacity conferred a 12 percent improvement in survival. CONCLUSIONS: Exercise capacity is a more powerful predictor of mortality among men than other established risk factors for cardiovascular disease.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa011858

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

4 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 36 references

Research works printed but not linked: 3

  1. Froelicher VF, 1996, Physicians and Computers, 14, 40
  2. American College of Sports Medicine. Guidelines for exercise testing and prescription. 6th ed. Baltimore: Lippincott Williams & Wilkins, 2000.
  3. Aaronson KD, 1995, J Heart Lung Transplant, 14, 981

Cited by

Items 201–300 of 1,025

Metadata

Authors
Myers, J., Prakash, M., Froelicher, V., Do, D., Partington, S., & Atwood, J. E.
Affiliations
VA Palo Alto Health Care System (US)
Venue
New England Journal of Medicine
Published
2002-03-14
Volume
346
Issue
11
Pages
793-801
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1971474283
Cited by
4,114
References
36
Citations by year
2026: 118 · 2025: 144 · 2024: 170 · 2023: 154 · 2022: 193 · 2021: 193 · 2020: 240 · 2019: 208 · 2018: 199 · 2017: 212 · 2016: 214 · 2015: 223 · 2014: 207 · 2013: 238 · 2012: 193
FWCI
206.69
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Keywords
exercise capacity, mortality prediction, treadmill exercise testing, cardiovascular disease, metabolic equivalents, maximal heart rate, blood pressure, beta-adrenergic blockade, healthy men, prognostic factors, cardiovascular risk
MeSH terms
Adrenergic beta-Antagonists, Aged, Blood Pressure, Cardiovascular Diseases, Exercise Test, Follow-Up Studies, Heart Rate, Humans, Male, Middle Aged, Mortality, Predictive Value of Tests, Prognosis, Risk, Risk Factors, ROC Curve, Body Mass Index, Proportional Hazards Models, Survival Analysis, Exercise Tolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.